Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2012, Article ID 609421, 13 pages
http://dx.doi.org/10.1155/2012/609421
Review Article

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder

1Mood Disorders Program and Women's Health Concerns Clinic, Department of Psychiatry and Behavioural Neurosciences, McMaster University, 301 James Street South, Suite F614, Hamilton, ON, Canada L8P 3B6
2Center of Oxidative Stress Research, Professor Tuiskon Dick Department of Biochemistry, Institute of Health Basic Sciences, Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos Street, 2600 Anexo, 90035-003 Porto Alegre, RS, Brazil

Received 4 February 2012; Accepted 2 March 2012

Academic Editor: Daniel Pens Gelain

Copyright © 2012 Guilherme A. Behr et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Guilherme A. Behr, José C. F. Moreira, and Benicio N. Frey, “Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 609421, 13 pages, 2012. https://doi.org/10.1155/2012/609421.